Evidence map›Paper›PMID 42146483›Full record

ArticlebioRxiv : the preprint server for biology2026

Cohesin bridging as a physical principle of enhancer-promoter communication.

Timothy Földes, Karissa L Hansen, Maxim Imakaev, Henrik D Pinholt, Nezar Abdennur, Geoffrey Fudenberg, Irié Carel, Tayma Handal, Fernanda Vargas-Romero, Elphège P Nora and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Timothy FöldesMassachusetts Institute of Technology, Institute for Medical Engineering and Science, Cambridge, MA, USA.ORCID 0000-0002-0951-4230
Karissa L HansenCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0352-5980
Maxim ImakaevMassachusetts Institute of Technology, Institute for Medical Engineering and Science, Cambridge, MA, USA.ORCID 0000-0002-5320-2728
Henrik D PinholtMassachusetts Institute of Technology, Institute for Medical Engineering and Science, Cambridge, MA, USA.
Nezar AbdennurDepartment of Genomics and Computational Biology, UMass Chan Medical School, Worcester, MA 01605, USA.ORCID 0000-0001-5814-0864
Geoffrey FudenbergDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90007, USA.ORCID 0000-0001-5905-6517
Irié CarelCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.
Tayma HandalCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.
Fernanda Vargas-RomeroCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0009-0000-5684-1659
Elphège P NoraCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-8347-4396
Leonid A MirnyMassachusetts Institute of Technology, Institute for Medical Engineering and Science, Cambridge, MA, USA.ORCID 0000-0002-0785-5410

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
Polymer models of mitotic and interphase chromosomesR01GM114190 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MIRNY, LEONID A · 2015 to 2023
$2.8M
Investigating the role of genome folding in transcriptional regulationR35GM142792 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NORA, ELPHEGE-PIERRE JULIEN · 2021 to 2025
$2.0M
NCI NIH HHS P30 CA082103NICHD NIH HHS T32 HD007470NIGMS NIH HHS R01 GM114190NIGMS NIH HHS R35 GM142792
6 · The paper itself

Abstract

Central to genome function, enhancers are non-coding sequences that can control transcription from promoters hundreds of kilobases away. Yet the physical basis of this long-range communication remains unclear. A prevalent view is that enhancers activate promoters when the two elements come into spatial proximity through the 3D folding of chromatin. However, activation by spatial proximity alone has struggled to explain several core features of enhancer function. Here, we propose that the molecular motor cohesin transmits long-range enhancer action by forming bridges between enhancers and promoters during loop extrusion. In this view, rare and transient bridges carry regulatory communication, rather than mere spatial proximity. We develop a quantitative model that predicts transcriptional output from cohesin-bridging dynamics and validate it by engineering cells in which strategically positioned CTCF sites rewire loop extrusion trajectories. The model explains how enhancer action scales with genomic distance, and how it can be either facilitated or insulated by CTCF sites across two orders of magnitude-behaviors incompatible with proximity-based models. Finally, our framework reveals that CTCF sites can block enhancers bidirectionally, by either blocking or releasing cohesin loops, resolving longstanding paradoxes between their effects on transcriptional regulation and genome folding. Together, our results establish cohesin bridging as a mode of enhancer-promoter communication that can be modulated by genomic context to achieve selective and tunable transcriptional control over long genomic distances.

Identifiers

PMID42146483
PMCPMC13174485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.